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ABSTRACT 
Urgency of the issue of rotavirus infection (RV) is stipulated by a special place in the 
structure of morbidity and mortality among young children. According to the data provided 
by WHO, 180 million diarrheal diseases with rotavirus etiology are registered every year. In 
Europe, 25 million children at the age of 5 years and younger are in need of medical care, and 
there are 2 million among them hospitalized each year. The specific prophylaxis is 
recommended in order to prevent these phenomena. Rotarix vaccine, which has cross 
protection against different strains (G1, G2, G3, G4 and G9), and RotaTed vaccine containing 
G serotypes (human serotypes G1, G2, G3, G4 and P1A and bovine serotypes G6, P7) are 
recommended. It has cross-protection against different strains. 
Key words: children, rotavirus infection, prophylaxis. 
Urgency of the issue of rotavirus infection (RV) is stipulated by a special place in the 
structure of morbidity and mortality among young children. According to the data provided 
by WHO, 180 million diarrheal diseases with rotavirus etiology are registered every year. In 
Europe 25 million children at the age of 5 years and younger are in need of medical care, and 
there are 2 million among them hospitalized each year. According to the data provided by 
Center for Disease Control and Prevention, in the United States 2.7 million cases are recorded 
among children of abovementioned age category, up to 70 thousand children are hospitalized 
and part of these cases has fatal outcome. On the basis of results of epidemic control of 
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rotavirus infection among children at the age of 5 years and younger, 46% of this pathogen of 
all intestinal infections are confirmed under laboratory conditions in Africa, 40% – in the 
countries of Middle East and South-East Asia, and 38% – in the countries of East Basin of 
Pacific Ocean [1]. 
The scientists who studied the incidence and mortality rates for the period 2000-2013 
noted that the worldwide number of deaths caused by rotavirus in children at the age of 5 
years and younger was 528000 in 2000 and in 2013 it was 215000. In 2013, 47100 deaths 
caused by rotavirus infection occurred in India, and 22% of all deaths are accounted for this 
pathogen. Four countries (India, Nigeria, Pakistan and Democratic Republic of the Congo) 
accounted for about half (49%) of all projected deaths caused by rotavirus infection in 2013 
[2]. 
In accordance with the data published by PubMed, the prevalence of rotavirus infections 
among children in China is 33.1%; in particular, children at the age of 24 months and younger 
were more susceptible to RVA infection with the level of infection up to 87.4% [3]. 
The scientists who conducted the studies in order to assess the prevalence of 
aforementioned infection and examined the strain genotypes of rotavirus, which causes acute 
gastroenteritis in children at the age of 5 years and younger in Iran, detected rotavirus in 
28.37% of total number of samples taken and recorded 72.91% of cases, which took place 
during the first 2 years of their life (p = 0.038). The highest infection prevalence was detected 
during summer period (52.5%) and the lowest prevalence was in winter period (7.50%) [4]. 
And on the contrary, in the countries with temperate climate the highest level of 
rotavirus gastroenteritis prevalence is observed during winter-spring period [5]. The 
frequency of rotavirus detection is 44% in January-February, and in other months this 
parameter is equal to 16.7% [1]. According to the data published by the regional office of 
WHO, in the territory of former Soviet Union in the past decade 24% of the acute rotavirus 
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enteritis among intestinal infections were recorded in Azerbaijan, 37% – in Georgia, 25% – in 
Kyrgyzstan, 28% – in Tajikistan, 30% – in Uzbekistan and 44% – in Ukraine [6]. In 2000-
2010, the incidence rate in Ukraine ranged from 0.93 to 3.18 per 100 thousand people 
(disagreement, clinical immunology). According to the data provided by different authors, in 
recent years the share of rotavirus diarrhea ranges from 35% to 75% in different countries 
with a tendency to constant growth [7]. 
In the world, rotaviruses are accounted for more than 25% of the deaths associated with 
diarrhea and 6% of the deaths among children at the age of 5 years and younger. Particularly 
in developing countries, rotavirus infection causes more than 850000 deaths each year [8]. 
For a long time medical professionals believed that rotavirus infection had only 
intestinal manifestations. However, in 1978 the first publications on the impairment of central 
nervous system by rotavirus, which results in convulsions, development of intussusception, 
erythema, heart and liver damage, occurred. Thus, in the retrospective studies of the group of 
infants with convulsions hospitalized in the Primary Children’s Medical Center, Salt Lake 
City, Utah, during the period from January 1, 2002, and December 31, 2006, the patients with 
rotavirus infection confirmed under laboratory conditions were detected. Afebrile convulsions 
at early stages were recorded in 68% of children [9]. The fact that rotavirus infection can 
cause neurological symptoms in young children was also established. However, the next 
question remains: why rotavirus infection has been missed as the cause of convulsions in 
infants for many years despite the significant research interest in neonatal rotavirus infection? 
[10] 
Also, rotaviruses are the most common cause of nosocomial infections in young 
children. 9.6% to 69% of healthcare-associated intestinal infections are connected with this 
infection. The rotavirus is determined in 50-70% of infants. The level of virus carriage in 
children is 1.5-95%, including neonatal period – 71%. 
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The etiological characteristics of pathogen include the fact that this virus belongs to the 
Reoviridae family; it received the genus name in 1978 (“rota” means wheel); this virus has 
size of 65-75 nm. According to antigenic properties, the rotaviruses are divided into 9 
serotypes, among which 1-4 and 8-9 serotypes are pathogenic for humans and 5-7 serotypes 
are found in animals. All human rotaviruses are divided taking into account the group-specific 
antigens, which are represented by proteins with inner capsid (A, B, C, D, E, F, G). However, 
90% of rotaviruses, which are pathogenic for humans, refer to the Group A. On the basis of 
proteins with outer capsid, the rotaviruses are divided into G- (VP4) and P- (VP7) subtypes. 
G1-G4 are the most common rotaviruses worldwide. G1-type has been dominating for many 
years, but recently G2, G3 and G9-types started prevailing. P4 and P8 are the most common 
types among P-types. However, the combinations of both types G1P8, G2P4, G3P8, G4P8, 
which cause the development of diarrhea, are the most widespread. Due to such heterogeneity 
recurrent cases of this disease are recorded [1]. Also, there are results of the studies, which 
indicate that P6 strains of RV are the most common types in Africa [11]. 
The virus has three membranes: outer layer (protein coat), inner capsid and core. RNA 
of the virus is unique; it consists of two strands and has 11 segments, which encode 6 
structural proteins (VP1-VP4, VP6, VP7) and 6 non-structural proteins (NSP1 – NSP6). Each 
protein is encoded by genomic segment, except for non-structural proteins 5 and 6 (NSP5, 
NSP6), which are encoded by the same segment. Two structural proteins - VP7 (glucoprotein 
or G-protein) and VP4 (P-protein split by protease) form the outer shell. The inner shell 
mostly consists of protein VP6, which is important for testing in order to determine antigens. 
NSP4 is the most probable virulence factor among the non-structural proteins. Presence of 
two protein capsids makes rotaviruses highly resistant to acidic stomach contents, gall, 
proteolytic enzymes and disinfectants [7]. 
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Rotaviruses are quite resistant to freezing and ultrasound but they are susceptible to 
boiling, action of acids and alkalis. They live in faeces for the period up to 7 months; they can 
be kept in tap water at the temperature of 40°C for 2 months, on the vegetables at t = 4°C for 
30 days. 
The source of rotavirus infection is the sick person who discharges virus with saliva, 
urine and faeces. Discharge of causative agent lasts for 3-6 days till the occurrence of clinical 
symptoms in 20-30 days. The cases of chronic diarrhea up to 66-450 days are described in 
literature [1]. 
The infection has faecal-oral mechanism of transmission; it spreads through contact-
household, food and water channels. Children at the age from 6 to 24 months are the most 
frequently affected. After the first infection, protection against the further infection is formed 
in 40% of children. The next cases of disease protect against the severe course. Recurrent 
cases are possible after 3 months. 
For a long time pathogenesis of rotavirus gastroenteritis was considered in quite 
simplified manner, and the following aspects were marked out: the virus gets into 
gastrointestinal tract through mouth. The virus replication takes place in enterocytes, which 
results in their dystrophy and necrotic changes. At the same time, the inflammatory response 
with increased infiltration develops, and it results in the acute enteritis with villous atrophy 
and catarrhal colitis. Also, the lack of enzymes, which split disaccharides, is observed and it 
causes the increase of osmotic pressure, which draws water and prevents its absorption 
resulting in diarrheal syndrome [5]. 
But the knowledge of the fact how rotavirus penetrates into human cells turned out to be 
very significant factor. Despite the progress made over the last decade in comprehension of 
the mechanisms, which explain the pathogenesis of rotavirus infection, there are many 
unsolved issues associated with the processes of rotavirus entry and internalization. The major 
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question is whether rotaviruses have alternative channels of entry, in particular, whether they 
can inhibit any of suggested receptors; also, it should be noted that the specialists have not 
succeeded in complete prevention of the virus at this stage. In order to enter into the target 
cell, rotaviruses use three types of cell surface molecules: 1
st
 type includes the molecules, 
which bond molecules represented by SA and certain integrins; 2
nd
 type represents 
chaperoning molecules, including Hsc70 and other heat shock proteins; and 3
rd
 type 
represents reduction-oxidation molecules including PDI, ERp57 and other molecules related 
to thioredoxin. Currently, the receptors for rotavirus, which fall into these main categories of 
molecules and support entry mechanisms, have been established. But other molecules, which 
have not been revealed yet, can also fulfill the same functions in other cell types and for other 
strains of rotavirus. Scientists have discovered the universal mechanism for the entry of 
rotavirus infection but the receptor molecules, which implement the entry mechanism, may 
differ in part or in whole depending on the type, cell line and rotavirus strain.  
Receptor use and rotavirus tropism are determined by certain number and location of 
receptors on the surface of host cell. Rotavirus structural proteins involved at the early stages 
of virus life cycle are the substrates of cell surface molecules, which contain oxidoreductase, 
thiol isomerase and Chaperone mechanisms responsible for the conformational changes of 
virus proteins, which interact and are necessary for internalization. 
Further studies should emphasize and determine the reasons why many receptors are 
used by rotaviruses. The fact that rotaviruses cause oxidative stress makes it possible to 
develop new therapeutic strategies for the inhibition of rotavirus infection and reveals the new 
method for treatment of life-threatening rotavirus diarrhea and supplement of existing 
vaccines. However, the main shortcoming in the comprehension of rotavirus infection 
strategy is the fact that rotaviruses resist the anti-inflammatory warning for replication but 
anti-inflammatory treatment inhibits the virus infection. This gap is a serious problem because 
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more detailed characteristics of the molecular mechanisms, which form the basis of rotavirus-
induced inflammatory warning, are needed. Another unsolved issue consists in the 
comprehension of rotavirus-induced oxidative stress and fact how antioxidant inhibits the 
virus infection during the treatment process [12]. 
Scientists express an interesting scientifically-based opinion on rotavirus entry into the 
host cell, which takes place through successive interactions between virion proteins and 
different host cell surface molecules. The mechanisms of entry are associated with cell 
molecules, which have chaperoning and oxidative processes. The receptor use and rotavirus 
tropism are determined by the type, cell line and rotavirus strain. As of today, the rotaviruses 
have evolved and they can resist the innate immune response, and at the same time they are 
capable to induce the endoplasmic reticulum (ER), oxidative stress and inflammatory signal 
transmission. The connection between ER stress, inflammation and oxidative stress is 
implemented with the release of calcium from ER, which increases the generation of 
mitochondrial reactive oxygen species (ROS) and results in toxic accumulation of reactive 
oxygen species in ER and mitochondria. Gradually, the stress potentially stimulates 
inflammatory response through the protein reaction paths. However, there is no detailed 
characteristic of molecule mechanisms, which form the basis of these induced stress 
conditions of rotavirus action. Signal events initiated by the recognition of host-virus 
associated molecule models enable the scientists to develop new therapeutic strategies aimed 
at the interference with rotavirus infection and reveal new methods for the development and 
supplement of vaccines [12]. 
Early studies of rotavirus infection revealed the reduction of SOD and glutathione 
peroxidase in the intestine of tested young mice [13]. More recent study showed that rotavirus 
infection is able to induce the increase of inducible nitric oxide synthase (INOS) of mRNA 
and expression of INOS when exposed to NSP4 [14]. NSP4-induced release of NO from 
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metabolites was detected in the culture of human intestinal epithelial cells [15]. Scientists 
recorded the increase of values of oxidative stress indices, including malondialdehyde (MDA) 
and NO concentration in blood serum, which were also associated with the pathological 
condition [16]. 
Connection of secretory diarrhea with NSP4 has significant importance in the study of 
rotavirus infection pathogenesis; NSP4 is a non-structural protein, which acts as bacterial 
enterotoxin disrupting the intracellular metabolism of calcium, potassium, sodium, chlorine 
and water and affecting the nerve terminals. It results in the accumulation of calcium inside 
the cells and causes the excretion of potassium, sodium, chlorine and water into the intestinal 
lumen. Disturbance of ion exchange and accumulation of proteins, which are foreign for the 
host organism and necessary for virus particle formation, cause the desquamation of 
enterocytes [1]. 
The clinical pattern of rotavirus infection is represented by various forms, 
gastroenteritis and gastroenterocolitis, in general. The incubation period is 1-5 days. Some 
experts described the symptomatology as DFV-syndrome (diarrhea, fever, vomiting) [1]. 
Basically, the following sequence of syndromes is observed: first 3 days – catarrhal 
syndrome with hyperthermia on the 3
rd
 day up to 38-39°, respiratory syndrome on the 3rd-4th 
day, then dyspeptic and intoxication syndromes. Defecation is foamy, watery with strong odor 
up to 5-20 times a day; there are imperative feelings of defecation. 
The severity of the child state is also stipulated by dehydration. The acetonemic 
syndrome (Cyclic Vomiting Syndrome – CVS syndrome) is observed in 81.1% of children 
who are older than 1 year; the frequency of vomiting increases by 15 times [1, 17]. 
The scientists explain such phenomena by the disorders in Krebs cycle – the universal 
method of energy conservation. Lipolysis stimulation is the metabolic basis of this syndrome. 
Fatty acids are transformed into acetyl-CoA in the liver. Under normal conditions, the basic 
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method of acetyl-CoA metabolism consists in the reaction with oxaloacetate with the further 
generation of energy. Part of acetyl-CoA is used for resynthesis of fatty acids and cholesterol. 
Only small portion is used for the formation of ketone bodies. In case of intense lipolysis, the 
excessive amount of acetyl-CoA is produced. Also, the activity of enzymes, which activate 
resynthesis of cholesterol and bile acids, decreases. As a result, there is basic method of 
acetyl-CoA utilization – formation of ketone bodies. Their level exceeds the functional 
capabilities of liver to utilize them, and it results in ketonemia, metabolic acidosis, 
ketoacidosis at the first stage; at the expense of condensation of 2 molecules of acetyl-CoA, 
the acetyl-CoA, which is metabolized into acetoacetic acid passing to ketone bodies – acetone 
and β hydroxy-butyric acid, is formed. First, the compensation of metabolic disorders takes 
place at the expense of hyperventilation, which causes hypocapnia and vasospasm, including 
cerebral vessels. Also, for the utilization of ketone bodies the additional quantity of oxygen is 
needed; it will cause the difference between supply and consumption. Penetrating into CNS, 
ketone bodies have adverse effect on the brain, they damage the lipid layer of cell membrane 
and irritate the vomiting center. Also, when there is vomiting, gastrointestinal tract is irritated 
and abdominal syndrome is observed. Ketone bodies are discharged through kidneys and 
respiratory organs, and it results in ketonuria and occurrence of acetone odor in exhaled air. 
Children with CVS syndrome are at risk group with regard to the development of diabetes 
during adolescence [17]. As is well-known, Taylor formulated the virus theory of 
development of diabetes of the 1
st
 type, the incidence rate of which has significantly increased 
in the world as of today [18]. Thus, in the authors’ opinion the study of the prevalence of 
development of diabetes of the 1
st
 type in children at the age of 5 years and older with genetic 
susceptibility and recurrent rotavirus gastroenteritis with accompanying acetonemic syndrome 
can be one of the urgent issues for the research by scientists, which has been analyzed to a 
small degree so far. The scientists who compared the data of ultrasound examination of 
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abdominal cavity organs in children with rotavirus infection have detected echocardiographic 
changes of pancreas in 66.6% and recorded the increase in echogenicity and granularity of 
parenchyma against the background of organ enlargement [7]. 
Authors who studied the immunological changes in the body of sick person noted that at 
the early stage of disease the protection takes place at the expense of secretory IgA (sIgA). In 
several days, IgM are included, and during rotavirus discharge from organism the antibodies 
to IgG occur providing the easier disease course in case of reinfection. The inhibition of 
cellular component, in particular T-helpers, and destruction of phagocytosis are observed. 
During the acute phase, the increase of serum interferon is noted; on the 7
th
-8
th
 day their 
decrease is noted, however, the function of interferon production of leukocytes is still 
reduced.  
Scientists established that interleukin 8 influences on the tissue immunity; the higher its 
level is, the more rotavirus antigens are in blood and at the same time IL-10 decreases [1]. 
Scientists who studied the levels of microelements noted the decrease of zinc, phosphor 
and copper and increase of iodine and iron in blood serum samples in 44.4% of cases [7]. 
The most common method of diagnostics consists in the detection of rotavirus antigen 
in stool samples using immune-enzyme assay. Electronic microscopy, reverse polymerase 
reaction, nuclein-acid hybridization, sequencing and virus culture examination, serological 
diagnostics can be used for scientific studies. Recently, the detection of rotavirus is performed 
using “cito test rota”. 
The differential diagnosis of rotavirus gastroenteritis is carried out with various 
intestinal infections using bacteriological and virological studies of vomit mass and 
excrements. The prior clinical diagnosis can be made on the basis of symptomatology. 
Cholera starts with diarrhea and vomiting occurs later; it is not accompanied by catarrh of the 
upper respiratory tract and abdominal pain. The following symptoms are typical for 
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salmonellosis: abundant and foamy mud-colored excrements, prolonged fever, enlargement of 
liver and spleen, leukocytosis. In case of dysentery, the syndrome of hemorrhagic colitis is the 
basic symptom. Adenovirus infection, at which rhinopharyngitis can also be combined with 
enteritis syndrome, is characterized by conjunctivitis, polyadenitis, enlargement of liver and 
spleen [1]. With rotavirus infection, such symptoms include secretory diarrhea and enteritis 
phenomena. There are several degrees of dehydration: mild degree – liquid loss up to 5% of 
body weight; moderate degree – liquid loss of 5% to 10% of body weight; severe degree – 
liquid loss of more than 10% of body weight. According to the content of electrolytes in the 
blood of patients with dehydration, in particular sodium, which is part of the extracellular 
fluid of organism and its osmolarity, three types of dehydration are determined: water-
deficient type, salt-deficient type and isotonic type. Monitoring of metabolic disorders is 
carried out according to the changes of parameters of acid-base balance, electrolytes and gas 
composition of venous blood. 
Patients with moderate and severe disease course are hospitalized. The diet is prescribed 
during the acute period. Timely and adequate compensation for water and electrolyte loss is 
the basis of treatment. As of today, rehydration is divided into oral and parenteral forms. In 
order to perform rehydration it is necessary to determine the following parameters: daily 
demand for liquid, type and degree of dehydration, current pathological losses, total deficit of 
liquid; also, it is required to determine the method of rehydration [19]. 
Oral (peroral) rehydration should be the first therapeutic measure, which is 
implemented at home with the occurrence of the first symptoms of disease. Rehydration is 
performed till the restoration of the volume of lost liquids and lasts for 4-6 hours. Rehydration 
is ineffective when dehydration increases, vomiting, profuse diarrhea, toxicosis symptoms 
continue; then, the infusion therapy is used. 
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It is required to calculate the rate of administration and daily volume of liquid, which is 
essential for child, using J. Dennis method: 1
st
 degree of dehydration: children at the age of 1 
year and younger – 140-170 ml/kg; children at the age of 1-5 years – 100-125 ml/kg; older 
children – 75-100 ml/kg. 2nd degree of dehydration: children at the age of 1 year and younger 
– 160-180 ml/kg; children at the age of 1-5 years – 130-170 ml/kg; older children – 110 
ml/kg. 3
rd
 degree of dehydration: children at the age of 1 year and younger – 200-220 ml/kg; 
children at the age of 1-5 years – 170-180 ml/kg; older children – 120-150 ml/kg. The most 
optimal solutions of crystalloids for parenteral rehydration in infants include 5% solution of 
glucose and 0.9% solution of sodium chloride and special solutions for parenteral rehydration. 
In case of isotonic dehydration, the volume ratio of 5% glucose solution and 0.9% NaCl 
solution is equal to 1:1. In case of hypertensive dehydration, the volume ratio of 5% glucose 
solution and 0.9% NaCl solution is equal to 3:1. In case of hypotonic dehydration, the volume 
ratio of 5% glucose solution and 0.9% NaCl solution is equal to 1:2. Potassium is the 
compulsory component of infusion therapy – Asparaginat K-Mg at the dose of 1 ml/kg per 
day. Contraindications for intravenous administration of potassium medicine include anuria or 
pronounced oliguria (less than 20 ml of urine per kg of body weight for 1 hour). 1-2 
ml/kg/day of 10% solution of calcium gluconate are added in case of the 3
rd
 degree of 
dehydration, pronounced microcirculation disorders, toxic, acidotic breathing, impairment of 
consciousness; 4% solution of sodium bicarbonate at the dose of 4 ml/kg/day is used. 
Properly performed infusion therapy is accompanied by elimination of dehydration symptoms 
in the first 24 hours. Then, it is required to calculate the volume of rehydration therapy for the 
following days: children at the age of 6 months and younger – 120-100 ml/kg; children at the 
age of 6 months-2 years – 100-80 ml/kg; children at the age of 2 years and older – 80-40 
ml/kg. 
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The use of enterosorbents significantly reduces diarrhea duration. Enterosorption 
duration is 5-7 days.  
The indications for antibacterial therapy in case of secretory diarrhea include children 
with immunodeficiency state and HIV-positive children who are on immunosuppressive 
therapy or having hemolytic anemia. Currently, the course of antibacterial therapy is 
recommended to be stepwise (3 days – parenteral method of administration, 2-5 days – enteral 
administration of medicine of macrolides or cephalosporins. Immunoglobulin of enteral origin 
is used in the treatment of rotavirus diarrhea: anti-colitis lactoglobulin, anti-rotavirus 
immunoglobulin, complex immunoglobulin medication for oral administration, triglobulin 
[19, 20]. 
Performed analysis of the data of systematic reviews of PubMed source demonstrates 
high interest of researchers in the study the clinical effects of the substances isolated from 
sea-buckthorn leaves (Hippophae Rhamnoides L.); there are about 20 studies, which confirm 
the great therapeutic potential of immunomodulatory, anti-inflammatory, protective, 
antioxidant, hepatoprotective and antimicrobial action [21]. 
Adjuvant therapy is applied for the correction of dysbiotic disorders of intestinal 
microbiocenosis using prebiotics, probiotics, symbiotics; they are prescribed for the period of 
1-2 months taking into account the coprogram data, examination results of faeces for 
dysbiosis. The most effective probiotics in case of intestinal infections include the following 
medicinal products [20]. 
Children who have recovered from severe form of rotavirus infection are subject to 
dispensary observation for six months. The patients are isolated for the period of 10-15 days. 
Current and final disinfection of premises, chamber treatment of clothes and bed linen are 
performed. The specific prophylaxis procedure is developed [22]. There are two live 
attenuated rotavirus vaccines. Rotarix is monovalent, peroral, freeze-dried vaccine restored by 
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the buffer CaCO3; it contains the human strain G1P8 and has cross protection against 
different strains (G1, G2, G3, G4 and G9). It is administered by two doses with OPV1, OPV2. 
RotaTed is pentavalent liquid vaccine containing G serotypes – human G1, G2, G3, G4 and 
P1A serotypes and bovine serotypes – G6, P7. It has cross protection against different strains; 
it is administered with OPV1, OPV2, OPV3 in three doses [6, 23]. 
Rotavirus vaccine is recommended for routine use in all countries of the world. In order 
to facilitate the process of decision making with regard to the use of rotavirus vaccine by the 
countries, researchers evaluated the mortality of children at the age of 5 years and younger 
caused by rotavirus during the period 2000-2013, and they collected and analyzed data in 
1998. The studies were performed using immune-enzyme assay. Scientists also included the 
data obtained from the countries, which participated in the World Health Organization 
(WHO), coordinated rotavirus surveillance network for the period 2008-2013 where these 
criteria were received. In order to predict the fate of diarrhea due to rotavirus, they built 
multiple linear regression models, studied the annual evaluations of certain countries. The 
result of this research contains the following information: rotavirus vaccine was administered 
in more than 60 countries worldwide by the end of 2013. Countries using the anti-rotavirus 
vaccine during the reporting period had low mortality rate; however, the impact of rotavirus 
vaccine in global evaluations of rotavirus mortality has limited character. Scientists continue 
to monitor rotavirus mortality via observation, and this fact assists in the spread of 
vaccination against this pathogen among children in many countries of the world [2]. 
Conclusion. Thus, due to the deterioration of the coverage of vaccination in Ukraine in 
2013-2016 and absence of mandatory vaccination against rotavirus infection at the state level, 
we have the task on reduction of the cases of rotavirus infection among children by improving 
the epidemic control, clinical detection, instant testing, proper treatment and promotion of 
vaccination; it is the key to health of the nation as European country. 
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